针对意外严重低温的内血管导管再加热的重症监护 (ICE-CRASH II):一种随机对照研究的协议
Shuhei Takauji1, Mineji Hayakawa2, Shoji Yokobori3
1Department of Emergency Medicine, Hokkaido University Hospital, Sapporo, Japan shutaka99@gmail.com.
BMJ open
|September 17, 2025
概括
血管内导管再加热是一种针对意外低温症 (AH) 的新疗法. 这项研究验证了它在严重的AH患者中与传统方法相比的有效性和安全性.
科学领域:
- 关键护理医学 关键护理医学
- 紧急医疗 紧急医疗
- 心血管研究研究心血管研究
背景情况:
- 意外低温 (AH) 构成显著的死亡风险,特别是在严重的病例中,可能导致致命的心室动.
- 血管内导管回暖正在成为传统的内部回暖方法 (如体外膜氧化 (ECMO)) 的不那么侵入性的替代方法.
- 目前的证据缺乏强有力的证明内血管导管回暖对AH管理的有效性和安全性.
研究的目的:
- 为了验证内血管导管再加热在意外严重低温的患者中的有效性和安全性.
- 为了比较通过内血管导管再加热与传统方法相结合的再加热率与单独使用传统的再加热率.
主要方法:
- 在意外严重低温症 (ICE-CRASH II) 研究中的内血管导管再加热的重症监护是多中心的随机试验.
- 它包括88名年龄≥65岁的患者,核心温度<30°C,血液循环保持.
- 患者接受内血管导管加常规升温或仅常规升温,结果在30天内进行评估.
主要成果:
- 主要结局是比较两组患者之间达到≥1.5°C/小时的回暖率的百分比.
- 将收集和分析二次结果和安全数据.
- 这项研究旨在提供关于这种创新的回暖技术有效性的最终数据.
结论:
- 这项研究将确定内血管导管再加热是否在严重的意外低温症中提供比传统方法更高或同等的再加热率.
- 结果将为管理意外低温的临床实践指南提供信息.
- 结果将为这一微创治疗方法的安全性和有效性提供关键证据.
相关概念视频
Decreased Body Temperature
1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K
Methods of reducing fever
1.2K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management
675
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
675
Continuous Renal Replacement Therapy
861
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
861


